This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks That Insiders Love Right Now

Clovis Oncology

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Insiders have been doing some decent buying in development-stage biopharmaceutical player Clovis Oncology (CLVS). Insiders are loading up on this stock into strength since shares are up over 33% so far in 2012.

Clovis Oncology has a market cap of $484 million and an enterprise value of $329 million. Its estimated growth rate for this year is 78.4%, and for next year it's pegged at -37.2%. This is a cash-rich company, since the total cash position on its balance sheet is $140.25 million and its total debt is zero.

A director just bought 25,000 shares, or $500,000 worth of stock, at $20.00 per share. This company also just announced a secondary offering of 3.75 million shares of common stock priced at $20 per share.

>>10 Stocks That Could Rise in Market Decline

From a technical perspective, CLVS is currently trading below its 50-day moving average, which is bearish. This stock IPOed back in November of last year, and since then it's soared from a low of $11.45 to a recent high of $27.55 a share. After hitting that high, the stock has dropped sharply with high-volume back below its 50-day to a recent low of $17.85.

If you're a bull on CLVS, I would only look for long-biased trades once this stock breaks out above some near-term overhead resistance at $19.20 to $20.50 a share with high volume. Look for volume on that move that's near or well above its three-month average action of 110,405 shares. It's worth pointing out that volume on Wednesday was 140,290 shares and the stock finished near its daily high of $19 a share. If we get that action soon, then this stock has a great chance to make a quick run at its 50-day moving average of $23.08 or possibly higher.

I would avoid any long trades in CLVS if this stock drops back below its recent low of $17.85 with volume. The downside could be big if CLVS loses that level since the next major support zone won't come into play until around $15 to $13 a share.

2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
CLVS $18.97 1.99%
ENPH $1.95 6.56%
END $0.01 -1.33%
WINA $93.00 3.45%
VPRT $63.72 -1.36%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs